We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Develops Pilot With NICE, Offers Parallel Scientific Advice
MHRA Develops Pilot With NICE, Offers Parallel Scientific Advice
May 18, 2010
Manufacturers with drugs in clinical development will have an opportunity to obtain parallel advice from both the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute of Health and Clinical Excellence (NICE) under a pilot program launched last month.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor